These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8140094)

  • 1. Structure-activity studies of human tumour necrosis factors.
    Van Ostade X; Tavernier J; Fiers W
    Protein Eng; 1994 Jan; 7(1):5-22. PubMed ID: 8140094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of human tumor necrosis factor-alpha.
    Shin HC; Cho KH
    Biotechnol Lett; 2005 Jan; 27(2):107-12. PubMed ID: 15703873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF alpha and the TNF receptor superfamily: structure-function relationship(s).
    Idriss HT; Naismith JH
    Microsc Res Tech; 2000 Aug; 50(3):184-95. PubMed ID: 10891884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of ligand binding by the human p55 tumour-necrosis-factor receptor. Involvement of individual cysteine-rich repeats.
    Corcoran AE; Barrett K; Turner M; Brown A; Kissonerghis AM; Gadnell M; Gray PW; Chernajovsky Y; Feldmann M
    Eur J Biochem; 1994 Aug; 223(3):831-40. PubMed ID: 8055960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionality of intrinsic disorder in tumor necrosis factor-α and its receptors.
    Uversky VN; El-Baky NA; El-Fakharany EM; Sabry A; Mattar EH; Uversky AV; Redwan EM
    FEBS J; 2017 Nov; 284(21):3589-3618. PubMed ID: 28746777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Woodchuck lymphotoxin-alpha, -beta and tumor necrosis factor genes: structure, characterization and biological activity.
    Li DH; Havell EA; Brown CL; Cullen JM
    Gene; 2000 Jan; 242(1-2):295-305. PubMed ID: 10721723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of BLyS receptor recognition.
    Oren DA; Li Y; Volovik Y; Morris TS; Dharia C; Das K; Galperina O; Gentz R; Arnold E
    Nat Struct Biol; 2002 Apr; 9(4):288-92. PubMed ID: 11862220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutant.
    Mukai Y; Shibata H; Nakamura T; Yoshioka Y; Abe Y; Nomura T; Taniai M; Ohta T; Ikemizu S; Nakagawa S; Tsunoda S; Kamada H; Yamagata Y; Tsutsumi Y
    J Mol Biol; 2009 Jan; 385(4):1221-9. PubMed ID: 19084540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site.
    Gordon NC; Pan B; Hymowitz SG; Yin J; Kelley RF; Cochran AG; Yan M; Dixit VM; Fairbrother WJ; Starovasnik MA
    Biochemistry; 2003 May; 42(20):5977-83. PubMed ID: 12755599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumour necrosis factor beta (lymphotoxin).
    Goh CR; Loh CS; Porter AG
    Protein Eng; 1991 Oct; 4(7):785-91. PubMed ID: 1665907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of extracellular human BAFF, a TNF family member that stimulates B lymphocytes.
    Karpusas M; Cachero TG; Qian F; Boriack-Sjodin A; Mullen C; Strauch K; Hsu YM; Kalled SL
    J Mol Biol; 2002 Feb; 315(5):1145-54. PubMed ID: 11827482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation.
    Mongkolsapaya J; Grimes JM; Chen N; Xu XN; Stuart DI; Jones EY; Screaton GR
    Nat Struct Biol; 1999 Nov; 6(11):1048-53. PubMed ID: 10542098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of human tumor necrosis factor-alpha muteins with improved therapeutic potential.
    Jang SH; Kim H; Cho KH; Shin HC
    BMB Rep; 2009 May; 42(5):260-4. PubMed ID: 19470238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human pro-tumor necrosis factor is a homotrimer.
    Tang P; Hung M-C ; Klostergaard J
    Biochemistry; 1996 Jun; 35(25):8216-25. PubMed ID: 8679576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structure of mouse tumour-necrosis factor at 1.4 A resolution: towards modulation of its selectivity and trimerization.
    Baeyens KJ; De Bondt HL; Raeymaekers A; Fiers W; De Ranter CJ
    Acta Crystallogr D Biol Crystallogr; 1999 Apr; 55(Pt 4):772-8. PubMed ID: 10089307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-2-induced tumor necrosis factor (TNF)-beta expression: further analysis in the IL-2 knockout model, and comparison with TNF-alpha, lymphotoxin-beta, TNFR1 and TNFR2 modulation.
    Reddy J; Chastagner P; Fiette L; Liu X; Thèze J
    Int Immunol; 2001 Feb; 13(2):135-47. PubMed ID: 11157847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TNF and TNF receptor superfamilies: integrating mammalian biology.
    Locksley RM; Killeen N; Lenardo MJ
    Cell; 2001 Feb; 104(4):487-501. PubMed ID: 11239407
    [No Abstract]   [Full Text] [Related]  

  • 18. Length of the linking domain of human pro-tumor necrosis factor determines the cleavage processing.
    Tang P; Hung M-C ; Klostergaard J
    Biochemistry; 1996 Jun; 35(25):8226-33. PubMed ID: 8679577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the lectin-like activity of tumor necrosis factor.
    Lucas R; Magez S; De Leys R; Fransen L; Scheerlinck JP; Rampelberg M; Sablon E; De Baetselier P
    Science; 1994 Feb; 263(5148):814-7. PubMed ID: 8303299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factors.
    Goetz FW; Planas JV; MacKenzie S
    Dev Comp Immunol; 2004 May; 28(5):487-97. PubMed ID: 15062645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.